Gene · 3134
Papers1,531
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,531
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell Type-Resolved Causal Inference and Spatial Transcriptomic Integration Reveal Immune-Specific Genetic Drivers of Autoimmune and Malignant Thyroid Disease. | Int J Immunogenet | 2026 | 42734902 | PubTator, text mining | PubMed |
| Emerging therapeutic opportunities targeting nonclassical MHC-I molecules. | Trends Mol Med | 2026 | 42604821 | PubTator, text mining | PubMed |
| Genetic Diversity and Haplotype Architecture of Non-Classical HLA Class I Genes in the Japanese Population. | HLA | 2026 | 42576171 | PubTator, text mining | PubMed |
| Application of single-cell RNA sequencing in preeclampsia. | Front Glob Womens Health | 2026 | 42367612 | PubTator, text mining | PubMed |
| Expanded Allelic Diversity of Non-Classical HLA Class I and MIC Loci Identified Using Full-Gene Hybrid Capture-Based Next-Generation Sequencing. | HLA | 2026 | 42366455 | PubTator, text mining | PubMed |
| Type I Interferon Regulation of HLA-F Expression in Human Trophoblasts During Viral Infection. | Viruses | 2026 | 42357613 | PubTator, text mining | PubMed |
| Spatial Analysis Identifies Endothelial HLA-F as a Prognostic Marker in Antibody-mediated Rejection. | Transplantation | 2026 | 42302751 | PubTator, text mining | PubMed |
| Last Licensed Non-Classical Peptide Presenter HLA-F: Its Occurrence, Immunoediting Significance, and Possible Therapeutic Implications in Renal Cell Carcinoma. | Int J Mol Sci | 2026 | 42278594 | PubTator, text mining | PubMed |
| PSD3 links autophagic flux to MHC-I-associated immune modulation in esophageal squamous cell carcinoma. | Apoptosis | 2026 | 42149295 | PubTator, text mining | PubMed |
| Nonclassical MHC-I Molecules: Emerging Therapeutic Targets in Next-Generation Immunotherapy. | MedComm (2020) | 2026 | 42027260 | PubTator, text mining | PubMed |
| Non-Classical HLA and MIC Risk Score Is Associated With Acute Kidney Transplant Rejection Beyond Classical HLA Matching. | HLA | 2026 | 41925073 | PubTator, text mining | PubMed |
| Endometrial immune markers are upregulated in the proliferative and secretory phases in recurrent pregnancy loss. | J Reprod Immunol | 2026 | 41886803 | PubTator, text mining | PubMed |
| Molecular signatures and causal factors underlying latent cytomegalovirus infection among people living with HIV (PLHIV). | Nat Commun | 2026 | 41881997 | PubTator, text mining | PubMed |
| Anti-HLA antibodies in lung transplantation: diagnostic pitfalls and future directions. | Eur Respir Rev | 2026 | 41813012 | PubTator, text mining | PubMed |
| The non-classical immune checkpoint HLA-G: a regulatory master switch governing tolerance, evasion, and translational frontiers. | Front Oncol | 2026 | 41800033 | PubTator, text mining | PubMed |
| Integrative Roles of NK Receptors and γδ TCRs in γδ T Cell-Mediated Cancer Immunity. | Immune Netw | 2026 | 41800030 | PubTator, text mining | PubMed |
| Ectopic CD11c Drives SMAD3-Mediated Aberrant Antigen Presentation and Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma. | Cancer Commun (Lond) | 2026 | 41799568 | PubTator, text mining | PubMed |
| Distribution and CWD Categories of HLA-E, -F, -G, -H, MICA and MICB Alleles, as Well as Homozygotes Across 17 Loci in the Chinese Population. | HLA | 2026 | 41797634 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis reveals cellular and molecular insights into gestational diabetes mellitus. | Front Mol Biosci | 2026 | 41788625 | PubTator, text mining | PubMed |
| Cuproptosis-related gene signatures define immune subtypes and predict prognosis in gastric cancer. | Front Mol Biosci | 2026 | 41737832 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3134/papers